Regulation of ocular surface inflammation by prostaglandin e receptor subtype EP3

Cornea

Volumn 29, Issue SUPPL. 1, 2010, Pages

  Ueta, Mayumi ^a,b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

EP3; ocular surface inflammation; prostaglandin (PG) E2

Indexed keywords

CYCLOOXYGENASE 2; EOTAXIN; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR SUBTYPE EP3; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL INFILTRATION; CONFERENCE PAPER; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; EYE DISEASE; EYE INFLAMMATION; EYELID; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PEMPHIGOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; STEVENS JOHNSON SYNDROME; WILD TYPE;

ANIMALS; CHEMOKINE CCL11; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYCLOOXYGENASE 2; DINOPROSTONE; EOSINOPHILS; EPITHELIUM; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78649269056     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181f5cd86     Document Type: Conference Paper

References (9)

1. Kunikata T, Yamane H, Segi E, et al. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol. 2005;6: 524-531.
2. Matsuoka T, Narumiya S. Prostaglandin receptor signaling in disease. Sci World J. 2007;7:1329-1347.
3. Ueta M, Matsuoka T, Narumiya S, et al. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol. 2009;123:466-471.
4. Honda T, Matsuoka T, Ueta M, et al. Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol. 2009;124:809-818.
5. Ueta M,Sotozono C, Nakano M, et al. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by genome-wide association study. J Allergy Clin Immunol. 2010. In press.
6. Morimoto K, Sugimoto Y, Katsuyama M, et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol. 1997;272:G681-G687.
7. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883-893.
8. Ueta M, Sotozono C, Yokoi N, et al. Prostaglandin E receptor subtype EP4 expression in devastating ocular surface disorders. Arch Ophthalmol. 2010. In press.
9. Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med. 2009;15:633-640.